Thursday, September 23, 2021

Contract doctors, fake vaccine certs on the list for Dewan discussion

The steps taken by the government to ensure that the Orang Asli do not drop out of the national vaccination programme are also scheduled for discussion.

Other News

Future plans for contract doctors, information on vaccine recipients who do not have identity cards as well as action to be taken against those who falsify vaccine certificates, are among the issues to be discussed in Parliament today.

According to the Order Paper of the Dewan Rakyat, Rusnah Aluai (PH-Tangga Batu) is scheduled to ask the health minister, during the oral question-and-answer session, about plans to guarantee the future of contract doctors.

Lukanisman Awang Sauni (GPS-Sibuti) meanwhile will seek clarification from the home minister on the government’s action over the information of vaccine recipients who do not have identity cards, especially in Sarawak, and action on the issue of individuals without identification documents.

Shaharizukirnain Abd Kadir (PAS-Setiu) will ask the home minister about action to be taken against those who falsify vaccination certificates.

Other issues that will be highlighted include the steps taken by the rural development ministry to ensure that the Orang Asli community does not drop out of the National Covid-19 Immunisation Programme, before the debate resumes on the motion of thanks on the royal address by the Yang di-Pertuan Agong.

Scheduled to be tabled for second reading are the Windfall Profit Levy (Amendment) Bill 2020, Occupational Safety and Health (Amendment) Bill 2020, Factories and Machinery (Repeal) Bill 2020, Malaysian Space Board Bill 2020 and Independent Police Conduct Commission Bill 2020.

Today is the second day of sitting of the fourth session of the 14th Parliament, under the government led by Prime Minister Ismail Sabri Yaakob.

The current sitting of the Dewan Rakyat will run for 17 days until Oct 12.

Follow us on Telegram for the latest updates: https://t.me/malaysianow

Subscribe to our newsletter

To be updated with all the latest news and analyses.

Related Articles